# FDA Inspection 1018002 - Resilience US, Inc. - June 27, 2017

Source: https://www.keypedia.com/records/fda_inspections/resilience-us-inc/e512d02e-e89d-4a88-8da6-8104c6c495fb
Source feed: FDA_Inspections

> FDA Inspection 1018002 for Resilience US, Inc. on June 27, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1018002
- Company Name: Resilience US, Inc.
- Inspection Date: 2017-06-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1258820 - 2025-01-21](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/3def6d42-7ce3-4bf9-bc57-c421ba00c6c1)
- [FDA Inspection 1099149 - 2019-08-09](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/50f1f32a-0c18-43b9-9f3d-9440dc865b90)
- [FDA Inspection 1099149 - 2019-08-09](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/bb778d86-f619-49cf-a26e-6b07f1e2c34c)
- [FDA Inspection 1043914 - 2018-03-08](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/5e71df58-ca79-476d-af51-50ceee60d664)
- [FDA Inspection 1028106 - 2017-09-07](https://www.keypedia.com/records/fda_inspections/resilience-us-inc/5006f9c6-0050-4ca8-bd61-0eabe9cea188)

Company: https://www.keypedia.com/companies/resilience-us-inc/864cabb1-d73c-4706-8d04-3e5c2375f44e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c